staining panck Search Results


90
Ultivue Inc staining panck
Staining Panck, supplied by Ultivue Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/staining panck/product/Ultivue Inc
Average 90 stars, based on 1 article reviews
staining panck - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Ultivue Inc panck immunofluorescence staining from ultivue 8-plex panel
Panck Immunofluorescence Staining From Ultivue 8 Plex Panel, supplied by Ultivue Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/panck immunofluorescence staining from ultivue 8-plex panel/product/Ultivue Inc
Average 90 stars, based on 1 article reviews
panck immunofluorescence staining from ultivue 8-plex panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Ultivue Inc panck immunofluorescence staining 8-plex panel
a , Digital image quantification of T cell markers (total CD3 + ), CD4 (CD3 + CD4 + ), cytotoxic (CD3 + CD8 + ), regulatory (CD3 + CD4 + FoxP3 + ) and co-staining for phenotypes (proliferating, Ki67 + ; activated, GrazB + ; PD-L1 + ) and combination of these phenotypes for the four patients referenced in Extended Data Fig. . Baseline biopsies were taken 2–5 weeks before afami-cel infusion. b , A multiparametric analysis of T cell infiltration in tumor biopsies using IHC, MAGE-A4 SPEAR RNAscope (Advanced Cell Diagnostics) and multiplex immunofluorescence. Images of post-infusion biopsy (liver) from Patient 4: A, spatial plot generated using spatial analysis module in HALO (Indica Labs) showing malignant cells (PanCK + (red), regulatory (CD3 + CD4 + FoxP3 + ) T cells (yellow) and cytotoxic (CD3 + CD8 + ) T cells (blue/cyan)). Scale bar is not applicable as this is not a raw image; B, CD3 IHC/SPEAR + T cell RNAscope duplex (CD3 IHC staining (blue); MAGE-A4 SPEAR T cell staining (purple)); C, Ultivue <t>8-plex</t> multiplex dataset showing CD4 (orange), PD-L1 (red), CD8 (green), Ki67 (purple), FoxP3 (blue), GrazB (white), CD3 (yellow) and PanCK (teal); D, PanCK immunofluorescence staining from Ultivue 8-plex panel (displayed in absorption mode in HALO for clarity); E, MAGE-A4 IHC stain (DAB (brown)); and F, hematoxylin (purple) and eosin (pink) stain. c , Heat map of log 2 -transformed normalized counts of genes associated with ‘T cell exhaustion’ and ‘Negative regulation of T cell-mediated immunity’ in baseline and post-infusion biopsies from Patients 1–4. Patients 1–3 were patients with SS; Patient 4 was a patient with ovarian cancer. DAB, 3,3′-diaminobenzidine; FoxP3, forkhead box protein 3; GrazB, granzyme B; Ov, ovarian; PanCK, pancytokeratin; PD-L1, programmed death ligand 1.
Panck Immunofluorescence Staining 8 Plex Panel, supplied by Ultivue Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/panck immunofluorescence staining 8-plex panel/product/Ultivue Inc
Average 90 stars, based on 1 article reviews
panck immunofluorescence staining 8-plex panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Haihang Industry Co Ltd virtual panck stains
a , Digital image quantification of T cell markers (total CD3 + ), CD4 (CD3 + CD4 + ), cytotoxic (CD3 + CD8 + ), regulatory (CD3 + CD4 + FoxP3 + ) and co-staining for phenotypes (proliferating, Ki67 + ; activated, GrazB + ; PD-L1 + ) and combination of these phenotypes for the four patients referenced in Extended Data Fig. . Baseline biopsies were taken 2–5 weeks before afami-cel infusion. b , A multiparametric analysis of T cell infiltration in tumor biopsies using IHC, MAGE-A4 SPEAR RNAscope (Advanced Cell Diagnostics) and multiplex immunofluorescence. Images of post-infusion biopsy (liver) from Patient 4: A, spatial plot generated using spatial analysis module in HALO (Indica Labs) showing malignant cells (PanCK + (red), regulatory (CD3 + CD4 + FoxP3 + ) T cells (yellow) and cytotoxic (CD3 + CD8 + ) T cells (blue/cyan)). Scale bar is not applicable as this is not a raw image; B, CD3 IHC/SPEAR + T cell RNAscope duplex (CD3 IHC staining (blue); MAGE-A4 SPEAR T cell staining (purple)); C, Ultivue <t>8-plex</t> multiplex dataset showing CD4 (orange), PD-L1 (red), CD8 (green), Ki67 (purple), FoxP3 (blue), GrazB (white), CD3 (yellow) and PanCK (teal); D, PanCK immunofluorescence staining from Ultivue 8-plex panel (displayed in absorption mode in HALO for clarity); E, MAGE-A4 IHC stain (DAB (brown)); and F, hematoxylin (purple) and eosin (pink) stain. c , Heat map of log 2 -transformed normalized counts of genes associated with ‘T cell exhaustion’ and ‘Negative regulation of T cell-mediated immunity’ in baseline and post-infusion biopsies from Patients 1–4. Patients 1–3 were patients with SS; Patient 4 was a patient with ovarian cancer. DAB, 3,3′-diaminobenzidine; FoxP3, forkhead box protein 3; GrazB, granzyme B; Ov, ovarian; PanCK, pancytokeratin; PD-L1, programmed death ligand 1.
Virtual Panck Stains, supplied by Haihang Industry Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/virtual panck stains/product/Haihang Industry Co Ltd
Average 90 stars, based on 1 article reviews
virtual panck stains - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a , Digital image quantification of T cell markers (total CD3 + ), CD4 (CD3 + CD4 + ), cytotoxic (CD3 + CD8 + ), regulatory (CD3 + CD4 + FoxP3 + ) and co-staining for phenotypes (proliferating, Ki67 + ; activated, GrazB + ; PD-L1 + ) and combination of these phenotypes for the four patients referenced in Extended Data Fig. . Baseline biopsies were taken 2–5 weeks before afami-cel infusion. b , A multiparametric analysis of T cell infiltration in tumor biopsies using IHC, MAGE-A4 SPEAR RNAscope (Advanced Cell Diagnostics) and multiplex immunofluorescence. Images of post-infusion biopsy (liver) from Patient 4: A, spatial plot generated using spatial analysis module in HALO (Indica Labs) showing malignant cells (PanCK + (red), regulatory (CD3 + CD4 + FoxP3 + ) T cells (yellow) and cytotoxic (CD3 + CD8 + ) T cells (blue/cyan)). Scale bar is not applicable as this is not a raw image; B, CD3 IHC/SPEAR + T cell RNAscope duplex (CD3 IHC staining (blue); MAGE-A4 SPEAR T cell staining (purple)); C, Ultivue 8-plex multiplex dataset showing CD4 (orange), PD-L1 (red), CD8 (green), Ki67 (purple), FoxP3 (blue), GrazB (white), CD3 (yellow) and PanCK (teal); D, PanCK immunofluorescence staining from Ultivue 8-plex panel (displayed in absorption mode in HALO for clarity); E, MAGE-A4 IHC stain (DAB (brown)); and F, hematoxylin (purple) and eosin (pink) stain. c , Heat map of log 2 -transformed normalized counts of genes associated with ‘T cell exhaustion’ and ‘Negative regulation of T cell-mediated immunity’ in baseline and post-infusion biopsies from Patients 1–4. Patients 1–3 were patients with SS; Patient 4 was a patient with ovarian cancer. DAB, 3,3′-diaminobenzidine; FoxP3, forkhead box protein 3; GrazB, granzyme B; Ov, ovarian; PanCK, pancytokeratin; PD-L1, programmed death ligand 1.

Journal: Nature Medicine

Article Title: Autologous T cell therapy for MAGE-A4 + solid cancers in HLA-A*02 + patients: a phase 1 trial

doi: 10.1038/s41591-022-02128-z

Figure Lengend Snippet: a , Digital image quantification of T cell markers (total CD3 + ), CD4 (CD3 + CD4 + ), cytotoxic (CD3 + CD8 + ), regulatory (CD3 + CD4 + FoxP3 + ) and co-staining for phenotypes (proliferating, Ki67 + ; activated, GrazB + ; PD-L1 + ) and combination of these phenotypes for the four patients referenced in Extended Data Fig. . Baseline biopsies were taken 2–5 weeks before afami-cel infusion. b , A multiparametric analysis of T cell infiltration in tumor biopsies using IHC, MAGE-A4 SPEAR RNAscope (Advanced Cell Diagnostics) and multiplex immunofluorescence. Images of post-infusion biopsy (liver) from Patient 4: A, spatial plot generated using spatial analysis module in HALO (Indica Labs) showing malignant cells (PanCK + (red), regulatory (CD3 + CD4 + FoxP3 + ) T cells (yellow) and cytotoxic (CD3 + CD8 + ) T cells (blue/cyan)). Scale bar is not applicable as this is not a raw image; B, CD3 IHC/SPEAR + T cell RNAscope duplex (CD3 IHC staining (blue); MAGE-A4 SPEAR T cell staining (purple)); C, Ultivue 8-plex multiplex dataset showing CD4 (orange), PD-L1 (red), CD8 (green), Ki67 (purple), FoxP3 (blue), GrazB (white), CD3 (yellow) and PanCK (teal); D, PanCK immunofluorescence staining from Ultivue 8-plex panel (displayed in absorption mode in HALO for clarity); E, MAGE-A4 IHC stain (DAB (brown)); and F, hematoxylin (purple) and eosin (pink) stain. c , Heat map of log 2 -transformed normalized counts of genes associated with ‘T cell exhaustion’ and ‘Negative regulation of T cell-mediated immunity’ in baseline and post-infusion biopsies from Patients 1–4. Patients 1–3 were patients with SS; Patient 4 was a patient with ovarian cancer. DAB, 3,3′-diaminobenzidine; FoxP3, forkhead box protein 3; GrazB, granzyme B; Ov, ovarian; PanCK, pancytokeratin; PD-L1, programmed death ligand 1.

Article Snippet: Scale bar is not applicable as this is not a raw image; B, CD3 IHC/SPEAR + T cell RNAscope duplex (CD3 IHC staining (blue); MAGE-A4 SPEAR T cell staining (purple)); C, Ultivue 8-plex multiplex dataset showing CD4 (orange), PD-L1 (red), CD8 (green), Ki67 (purple), FoxP3 (blue), GrazB (white), CD3 (yellow) and PanCK (teal); D, PanCK immunofluorescence staining from Ultivue 8-plex panel (displayed in absorption mode in HALO for clarity); E, MAGE-A4 IHC stain (DAB (brown)); and F, hematoxylin (purple) and eosin (pink) stain. c , Heat map of log 2 -transformed normalized counts of genes associated with ‘T cell exhaustion’ and ‘Negative regulation of T cell-mediated immunity’ in baseline and post-infusion biopsies from Patients 1–4.

Techniques: Staining, Multiplex Assay, Immunofluorescence, Generated, Immunohistochemistry, Transformation Assay